real-time or multiplex polymerase-chain-reaction biofire filmarray rp2.1 (BioFire Defense)
Structured Review
Real Time Or Multiplex Polymerase Chain Reaction Biofire Filmarray Rp2.1, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/filmarray+rp2%2E1+assay/biofire+rp2+1/pm40214813-43-20-24
Average 90 stars, based on 1 article reviews
Images
Related Articles
Multiplex Assay:Article Title: Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala Article Snippet: The first 40 available ILI specimens collected through April 2021 and shipped to the University of Colorado were also tested for an additional 15 respiratory pathogens by using the Article Title: SARS-CoV-2 spike protein diversity at an intra-host level, among SARS-CoV-2 infected individuals in South Africa, 2020 to 2022 Article Snippet: Multiplex real-time reverse transcription-based polymerase chain reaction (rRT-PCR) assays were performed on total nucleic acid according to the manufacturers’ instructions: a) AllplexTM 2019-nCoV Assay (Seegene Inc., Korea) was tested with the CFX96 real-time platform (Bio-Rad, California, United States); b) TaqPath COVID-19 assay (Thermo Fisher Scientific) was tested with the QuantStudio TM 5 (Thermo Fisher Scientific) real-time platform; c) the cobas ® SARS-CoV-2 assay (Roche Diagnostics) was processed with the cobas ® 8800 platform (Roche Diagnostics); and d) the Reverse Transcription Polymerase Chain Reaction:Article Title: Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala Article Snippet: The first 40 available ILI specimens collected through April 2021 and shipped to the University of Colorado were also tested for an additional 15 respiratory pathogens by using the Article Title: SARS-CoV-2 spike protein diversity at an intra-host level, among SARS-CoV-2 infected individuals in South Africa, 2020 to 2022 Article Snippet: Multiplex real-time reverse transcription-based polymerase chain reaction (rRT-PCR) assays were performed on total nucleic acid according to the manufacturers’ instructions: a) AllplexTM 2019-nCoV Assay (Seegene Inc., Korea) was tested with the CFX96 real-time platform (Bio-Rad, California, United States); b) TaqPath COVID-19 assay (Thermo Fisher Scientific) was tested with the QuantStudio TM 5 (Thermo Fisher Scientific) real-time platform; c) the cobas ® SARS-CoV-2 assay (Roche Diagnostics) was processed with the cobas ® 8800 platform (Roche Diagnostics); and d) the |
